These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37263188)

  • 1. Hemoperfusion: Indications, Dose, Prescription.
    Bidar F; Abrard S; Lamblin A; Rimmelé T
    Contrib Nephrol; 2023; 200():88-97. PubMed ID: 37263188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemoperfusion in anesthesia and intensive care medicine: benefits, risks, and evidence for different systems].
    Gräfe C; Weidhase L; Liebchen U; Weigand MA; Scharf C
    Anaesthesiologie; 2023 Dec; 72(12):843-851. PubMed ID: 37707564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncertain Clinical Effect of Polymyxin B Hemoperfusion in Patients with Septic Acute Kidney Injury Requiring Continuous Renal Replacement Therapy.
    Lee JM; Baek SD; Kim TH; Jeon HR; Han JH; Chang JW
    Shock; 2021 Oct; 56(4):551-556. PubMed ID: 33606479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients.
    Srisawat N; Tungsanga S; Lumlertgul N; Komaenthammasophon C; Peerapornratana S; Thamrongsat N; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S; Tungsanga K; Kellum JA
    Crit Care; 2018 Oct; 22(1):279. PubMed ID: 30367647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence and Perspectives on the Use of Polymyxin B-Immobilized Fiber Column Hemoperfusion among Critically Ill Patients.
    Yamashita C; Moriyama K; Hasegawa D; Hara Y; Kuriyama N; Nakamura T; Shibata J; Komura H; Nishida O
    Contrib Nephrol; 2018; 196():215-222. PubMed ID: 30041230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of polymyxin B-immobilized fiber hemoperfusion on sepsis-induced rhabdomyolysis with acute renal failure.
    Nakamura T; Ushiyama C; Suzuki S; Shoji H; Shimada N; Sekizuka K; Ebihara I; Koide H
    Nephron; 2000 Oct; 86(2):210. PubMed ID: 11015003
    [No Abstract]   [Full Text] [Related]  

  • 7. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
    Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
    JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue therapy with polymyxin B hemoperfusion in high-dose vasopressor therapy refractory septic shock.
    Monti G; Terzi V; Calini A; Di Marco F; Cruz D; Pulici M; Brioschi P; Vesconi S; Fumagalli R; Casella G
    Minerva Anestesiol; 2015 May; 81(5):516-25. PubMed ID: 25319136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.
    Fujii T; Ganeko R; Kataoka Y; Furukawa TA; Featherstone R; Doi K; Vincent JL; Pasero D; Robert R; Ronco C; Bagshaw SM
    Intensive Care Med; 2018 Feb; 44(2):167-178. PubMed ID: 29204670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Effects and Outcomes After Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Treatment for Septic Shock in Preterm Neonates.
    Nishizaki N; Hara T; Obinata K; Nakagawa M; Shimizu T
    Pediatr Crit Care Med; 2020 Feb; 21(2):156-163. PubMed ID: 31568052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoperfusion in COVID-19.
    Lertussavavivat T; Srisawat N
    Contrib Nephrol; 2023; 200():192-200. PubMed ID: 37263252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbation of prothrombin time-international normalized ratio before second polymyxin B cartridge hemoperfusion predicts poor outcome of patients with severe sepsis and/or septic shock.
    Ishizuka M; Terasaki A; Kubota K
    J Surg Res; 2016 Jan; 200(1):308-14. PubMed ID: 26319975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of endotoxin absorber hemoperfusion on microcirculation in septic pigs.
    Yeh YC; Yu LC; Wu CY; Cheng YJ; Lee CT; Sun WZ; Tsai JC; Lin TY;
    J Surg Res; 2017 May; 211():242-250. PubMed ID: 28501124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Extended Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion on Hemodynamics, Vasoactive Substance Requirement, and Pulmonary Oxygenation in Patients with Sepsis: An Observational Study.
    Mitaka C; Kusao M; Kawagoe I; Satoh D; Iba T; Ronco C
    Blood Purif; 2022; 51(1):62-69. PubMed ID: 33910191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis.
    Li X; Liu C; Mao Z; Qi S; Song R; Zhou F
    J Crit Care; 2021 Jun; 63():187-195. PubMed ID: 33012579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
    Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
    Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Polymyxin Hemoperfusion in Complex Therapy of Sepsis in Children after Cardiac Surgery.
    Yaroustovsky M; Abramyan M; Rogalskaya E; Komardina E
    Blood Purif; 2021; 50(2):222-229. PubMed ID: 33242859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymyxin B hemoperfusion in clinical practice: the picture from an unbound collaborative registry.
    Early Use of Polymyxin B Hemoperfusion in the Abdominal Sepsis 2 Collaborative Group
    Blood Purif; 2014; 37 Suppl 1():22-5. PubMed ID: 24457492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis.
    Chang T; Tu YK; Lee CT; Chao A; Huang CH; Wang MJ; Yeh YC
    Crit Care Med; 2017 Aug; 45(8):e858-e864. PubMed ID: 28445237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.
    Dellinger RP; Bagshaw SM; Antonelli M; Foster DM; Klein DJ; Marshall JC; Palevsky PM; Weisberg LS; Schorr CA; Trzeciak S; Walker PM;
    JAMA; 2018 Oct; 320(14):1455-1463. PubMed ID: 30304428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.